ITEMS IN AFP WITH KEYWORD:
Adult vaccinations are underutilized despite proven efficacy and cost-effectiveness. There are many barriers to immunization that are more prominent in adults than in children, including cost, lack of tracking systems, and competing demands.
The Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention provides general guidelines for the administration of its recommended routine vaccinations, which are aimed at preventing 17 diseases in children and adults. Sections of this guideline were rece...
Oct 1, 2011 Issue
ACIP Updates Guideline on Influenza Vaccination for 2011-2012 Season [Practice Guidelines]
The Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention has issued its annual guideline on vaccination against influenza. It includes information on a newly licensed intradermal vaccine, a change in the number of vaccine doses required in children si...
Sep 1, 2011 Issue
Acellular Vaccines for Preventing Pertussis in Children [Cochrane for Clinicians]
Multicomponent (i.e., three or more) acellular vaccines are as effective as whole-cell vaccines at preventing pertussis and mild pertussis disease (e.g., cold symptoms, cough without classic whoop or cough paroxysms) in children. Adverse effects are similar to those from placebo and less severe than those from whole-cell vaccines.
Each year the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention updates the recommended immunization schedules for children, adolescents, and adults. These schedules describe the immunizations recommended for routine administration in each age grou...
American Academy of Pediatrics (AAP) releases recommendations on Streptococcus pneumoniae vaccination. In February 2010, the U.S. Food and Drug Administration licensed a 13-valent pneumococcal conjugate vaccine (PCV13; Prevnar 13) for use in children two through 71 months of age. PCV13 will replace PCV7.
Oct 1, 2010 Issue
CDC Updates Guidelines for Influenza Vaccination for 2010-2011 Season [Practice Guidelines]
The Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC) has released updated recommendations on influenza control for the 2010–2011 season. Seasonal influenza vaccines in 2010–2011 will contain A/California/7/2009 (H1N1)-like, A/Perth/16/2009 (...
Oct 1, 2010 Issue
Influenza Vaccination of Health Care Personnel Working with Older Patients [Cochrane for Clinicians]
Currently, there is no high-quality evidence to support the immunization of health care personnel in long-term care facilities to reduce the spread of seasonal influenza to older residents. Immunization of personnel did reduce influenza-like illness and all-cause mortality in the residents; however,...
Sep 1, 2010 Issue
AAP Updates Guidelines on Immunoprophylaxis for RSV Infection [Practice Guidelines]
Although RSV bronchiolitis usually manifests as acute upper respiratory tract infection, more serious disease involving the lower respiratory tract can develop. Preterm infants and those with congenital heart disease (CHD) or chronic lung disease of prematurity (also called bronchopulmonary dysplasi...
A live, oral human-bovine reassortant rotavirus vaccine (RV5; Rotateq) was approved in 2006, followed by a live, oral human attenuated rotavirus vaccine (RV1; Rotarix) in 2008. Since the licensure of RV1, the American Academy of Pediatrics (AAP) has updated its guidelines on the routine use of rotavirus vaccine in infants.